DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE CLR222US

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2019-09-24 for DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE CLR222US manufactured by Ethicon Inc..

Event Text Entries

[162975242] Product complaint # (b)(4). The following additional information was requested and obtained: what does the reaction look like and how large of an area does the reaction cover? After further investigation the reaction that the doctor was experiencing was not a chemical reaction. The surgeon experienced oozing of blood and slight dehiscence. I will discuss some homeostasis products to address this issue. Do you have any pictures of the reaction? No. Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? If so, please clarify. N/a. What is the most current patient status? The doctor changed the patients dressing with something other than prineo. Was prineo/dermabond or skin adhesive used on the patient in a previous surgery or wound closure? N/a. The following additional information has been requested but no response received to date: what date did the reaction / dehiscence occur post op? What medical / surgical treatment was provided to treat the dehiscence? What medical / surgical treatment was provided to treat the reaction? Lot number? Describe the reaction (e. G. Blister/red/infected/mild) what prep was used prior to, during or after prineo use? How many layers of adhesive were used over during application? Was a dressing placed over the incision? If so, what type of cover dressing used? Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? What is the physicians opinion of the contributing factors to the reaction? Patient demographics: initials / id; age or date of birth; bmi, gender. Patient pre-existing medical conditions (ie. Allergies, history of reactions). Was prineo/demabond or skin adhesive used on the patient in a previous surgery or wound closure? What was the patient outcome? To date the device has not been returned. If the device or further details are received at a later date a supplemental medwatch will be sent.
Patient Sequence No: 1, Text Type: N, H10


[162975243] It was reported a patient underwent a total hip replacement procedure on (b)(6) 2019 and topical skin adhesive was used. Post operatively, the patients developed bumps and skin reactions, wound dehiscence and discharge. The doctor changed the patients dressing with something other than adhesive. Additional information has been requested.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2019-88035
MDR Report Key9111294
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2019-09-24
Date of Report2019-08-27
Date of Event2019-08-27
Date Mfgr Received2019-10-24
Date Added to Maude2019-09-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 088760151
Manufacturer CountryUS
Manufacturer Postal088760151
Manufacturer Phone6107428552
Manufacturer G1ETHICON INC.-SAN LORENZO PR
Manufacturer StreetROAD 183, KM. 8.3
Manufacturer CitySAN LORENZO 00754
Manufacturer Postal Code00754
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE
Generic NameSURGICAL SEALANT
Product CodeOMD
Date Received2019-09-24
Catalog NumberCLR222US
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 088760151 US 088760151


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-09-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.